Current Cardiovascular Risk Reports

, Volume 7, Issue 3, pp 212–216

Women and Heart Failure: An Emerging Venus-Mars Concept

Women and Heart Disease (J Robinson, Section Editor)


Some of the most profound sex differences in cardiovascular disease are evident in the syndrome of heart failure. Certain heart failure conditions have a unique predilection for women, such as heart failure with preserved ejection fraction and apical ballooning syndrome; or are exclusive to women, such as peripartum cardiomyopathy. Overall, there are notable differences between women and men in terms heart failure disease burden, risk factors, clinical presentation and prognosis. Yet, women remain under-represented in heart failure clinical trials. Important knowledge gaps exist in our understanding of the pathophysiologic basis for these sex differences and potential for effective sex-specific management strategies.


Heart failure Gender differences Sex Cardiomyopathy 


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Velagaleti RS, Gona P, Larson MG, et al. Multimarker approach for the prediction of heart failure incidence in the community. Circulation. 2010;122:1700–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics−−2012 Update: a report from the American Heart Association. Circulation. 2012;125:e2–220.PubMedCrossRefGoogle Scholar
  3. 3.
    Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251–2594.PubMedCrossRefGoogle Scholar
  4. 4.
    Borlaug BA, Redfield MM. Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation. 2011;123:2006–14.PubMedCrossRefGoogle Scholar
  5. 5.
    Hsich EM, Pina IL. Heart failure in women: A need for prospective data. J Am Coll Cardiol. 2009;54:491–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Rho RW, Patton KK, Poole JE, et al. Important differences in mode of death between men and women with heart failure who would qualify for a primary prevention implantable cardioverter-defibrillator. Circulation. 2012;126:2402–7.PubMedCrossRefGoogle Scholar
  7. 7.
    •• Martinez-Selles M, Doughty RN, Poppe K, et al. Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis. Eur J Heart Fail. 2012;14:473–9. This meta-analysis represents the largest assessment of the association of sex and heart failure survival rates.PubMedCrossRefGoogle Scholar
  8. 8.
    Hsich EM, Grau-Sepulveda MV, Hernandez AF, et al. Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction. Am Heart J. 2012;163(3):430–7.PubMedCrossRefGoogle Scholar
  9. 9.
    •• Scantlebury DC, Borlaug BA. Why women are more likely then men to develop heart failure with preserved ejection fraction? Curr Opin Cardiol. 2011;26:562–8. Why women are more likely then men to develop heart failure with preserved ejection fraction?.PubMedCrossRefGoogle Scholar
  10. 10.
    Fujimoto N, Borlaug BA, Lewis GD, et al. Hemodynamic responses to rapid saline loading: the impact of age, sex, and heart failure. Circulation. 2013;127(1):55–62.PubMedCrossRefGoogle Scholar
  11. 11.
    Piro M, Della Bona R, Abbate A, et al. Sex-related differences in myocardial remodeling. J Am Coll Cardiol. 2010;55:1057–65.PubMedCrossRefGoogle Scholar
  12. 12.
    Petrov G, Regitz-Zagrosek V, Lehmkuhl E, et al. Regression of myocardial hypertrophy after aortic valve replacement: faster in women? Circulation. 2010;122(11 Suppl):S23–8.PubMedCrossRefGoogle Scholar
  13. 13.
    De Simone G, Devereux RB, Chinali M, et al. Sex differences in obesity related changes in left ventricular morphology: the strong heart study. J Hypertens. 2011;29:1431–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Rossi P, Frances Y, Kingwell BA, et al. Gender differences in artery wall biomechanical properties throughout life. J Hypertens. 2011;29:1023–33.PubMedCrossRefGoogle Scholar
  15. 15.
    Borlaug BA. Sex, load and relaxation; are women more susceptible to load-dependent diastolic dysfunction? J Am Coll Cardiol. 2011;57:1234–6.PubMedCrossRefGoogle Scholar
  16. 16.
    •• Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J. 2011;32(6):670–9. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment.PubMedCrossRefGoogle Scholar
  17. 17.
    • Lam CS, Donal E, Kraigher-Krainer E, et al. Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail. 2011;13(1):18–28. This article gives a comprehensive review of the current epidemiology trends and clinical course and disease outcomes of HFpEF.PubMedCrossRefGoogle Scholar
  18. 18.
    Melander O, Maisel AS, Almgren P, et al. Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality. JAMA. 2012;308(14):1469–75.PubMedCrossRefGoogle Scholar
  19. 19.
    • Lam CS, Carson PE, Anand IS, et al. Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the i-preserve trial. Circ Heart Fail. 2012;5(5):571–8. This article represents the largest and most representative study of HFpEF with a sex-specific analysis and outcomes.PubMedCrossRefGoogle Scholar
  20. 20.
    Looi JL, Wong CW, Khan A, et al. Clinical characteristics and outcome of apical ballooning syndrome in Auckland, New Zealand. Heart Lung Circ. 2012;21(3):143.PubMedCrossRefGoogle Scholar
  21. 21.
    Brinjikji W, El-Sayed AM, Salka S. In-hospital mortality among patients with takotsubo cardiomyopathy: a study of the National Inpatient Sample 2008 to 2009. Am Heart J. 2012;164(2):215–21.PubMedCrossRefGoogle Scholar
  22. 22.
    • Eitel I, von Knobelsdorff-Brekenhoff F, Bernhardt P, et al. Clinical characteristics and CV magnetic resonance findings in stress (Takotsubo) cardiomyopathy. JAMA. 2011;306:277–86. This article describes the clinical characteristics of ABS is a large multicenter cohort, and has the largest magnetic resonance imaging series of ABS to date.PubMedCrossRefGoogle Scholar
  23. 23.
    Maron BJ, Towbin JA, Thiene G, et al. American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; Council on Epidemiology and Prevention. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113(14):1807–16.PubMedCrossRefGoogle Scholar
  24. 24.
    Deshmukh A, Kumar G, Pant S, et al. Prevalence of Takotsubo cardiomyopathy in the United States. Am Heart J. 2012;164(1):66–71.PubMedCrossRefGoogle Scholar
  25. 25.
    Cacciotti L, Passaseo I, Marazzi G, et al. Observational study on Takotsubo-like cardiomyopathy: clinical features, diagnosis, prognosis and follow-up. BMJ Open. 2012;2:e001165.PubMedCrossRefGoogle Scholar
  26. 26.
    • Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol. 2011;58(7):659–70. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management.PubMedCrossRefGoogle Scholar
  27. 27.
    Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12:767–78.PubMedCrossRefGoogle Scholar
  28. 28.
    Burlingame J, Horiuchi B, Ohana P, et al. The contribution of heart disease to pregnancy-related mortality according to the pregnancy mortality surveillance system. J Perinatol. 2012;32(3):163–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Biteker M, Ilhan E, Biteker G, et al. Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow-up and sustained therapy. Eur J of Heart Fail. 2012;14(8):895–901.CrossRefGoogle Scholar
  30. 30.
    Goland S, Bitar F, Modi K, et al. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy. J Card Fail. 2011;17(5):426–30.PubMedCrossRefGoogle Scholar
  31. 31.
    Biteker M, Duran NE, Kaya H, et al. Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial. Clin Res Cardiol. 2011;100:571–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Gevaert S, Van Belleghem Y, Bouchez S, et al. Acute and critically ill peripartum cardiomyopathy and ‘bridge to’ therapeutic options: a single center experience with intra-aortic balloon pump, extra corporeal membrane oxygenation and continuous-flow left ventricular assist devices. Crit Care. 2011;15:R93.PubMedCrossRefGoogle Scholar
  33. 33.
    Sliwa K, Blauwet L, Tibazarwa K, et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation. 2010;121(13):1465–73.PubMedCrossRefGoogle Scholar
  34. 34.
    Ballo P, Betti I, Mangialavori G, et al. Peripartum Cardiomyopathy Presenting with Predominant Left Ventricular Diastolic Dysfunction: Efficacy of Bromocriptine. Case Rep Med. 2012;2012:476903.PubMedGoogle Scholar
  35. 35.
    Safirstein JG, Ro AS, Grandhi S, et al. Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet. Int J Cardiol. 2012;154(1):27–31.PubMedCrossRefGoogle Scholar
  36. 36.
    Mandal D, Mandal S, Mukherjee D, et al. Pregnancy and subsequent pregnancy outcomes in peripartum cardiomyopathy. J Obstet Gynaecol Res. 2011;37:222–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Pyatt JR, Dubey G. Peripartum cardiomyopathy: current understanding, comprehensive management review and new developments. Postgrad Med J. 2011;87:34–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.National University Heart CentreFrom the National University Health SystemSingaporeSingapore

Personalised recommendations